Purchase Order 1232SC18P0202
- Not listed
- The U.S. government awarded a $9,220 firm fixed-price purchase order to Psomagen Inc. for DNA library preparation and sequencing services, including additional quality control for replacement samples. The contract was set aside for small businesses and awarded on February 13, 2019, with an ultimate completion date of June 21, 2019. Work is being performed in Potomac, Maryland, and the funding agency is identified as the Northeast Area civilian federal agency component. Psomagen Inc., a...
- The U.S. government awarded a $12.5K firm fixed-price purchase order to Psomagen Inc. for sequencing services on April 15, 2016. The contract, which was not designated as a set-aside, was funded by a civilian agency within the Southeast Area and required performance in Potomac, Maryland, with an ultimate completion date of September 30, 2017. Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland, and a subsidiary of Macrogen Inc., provided the sequencing...
- This federal contract represents a ratifying order for sequencing services awarded to Psomagen Inc., a genomics and molecular biology services company subsidiary of Macrogen, Inc., on April 10, 2018. The purchase order carries a ceiling value of $2,718.65 under a firm fixed-price contract type with no set-aside designation. The work will be performed in Potomac, Maryland, and is funded by a civilian federal agency's Southeast Area office. Psomagen specializes in advanced genomic sequencing,...
- The U.S. federal government awarded a $31,368 purchase order to Psomagen Inc., a genomics and molecular biology services company headquartered in Rockville, Maryland, for Illumina High-Seq 2x150bp sequencing services generating gigabase output per lane. The contract, awarded on September 6, 2019, with an ultimate completion date of September 20, 2019, was issued without set-aside designation and was funded through a civilian federal agency's Southeast Area office. Work was performed at a...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- The U.S. Food and Drug Administration (FDA) awarded a $19,380 firm fixed-price purchase order for whole genome sequencing services on the Illumina NovaSeq X platform to Psomagen Inc., a small business contractor. The contract has a completion date of September 19, 2025. Psomagen is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities to provide genomic sequencing, bioinformatics, and related services to federal agencies. This award is a small business...
- This federal contract award, valued at $10,000.00, was issued by the United States Department of Agriculture (USDA) Forest Service Research Service Rocky Mountain Research Station to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for DNA sequencing services with a completion date of September 5, 2025. Psomagen Inc. is a provider of genomic and molecular biology services to various federal agencies, including the National Institutes of Health (NIH) and the USDA. The company has...
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland. The $180,000 contract has a period of performance ending on May 19, 2025. Psomagen Inc. is a subsidiary of the parent company Macrogen, Inc., which is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. The contract does not have a...
- This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
- This is a firm-fixed-price purchase order awarded by the Southeast Area of a civilian federal agency to Psomagen Inc., a small business and subsidiary of Macrogen, Inc. The $9,370.00 contract is for soil microbe sequencing services, with a performance period ending on August 9, 2024. Psomagen is a provider of advanced genomic and molecular biology services, including capabilities in whole genome sequencing, RNA sequencing, epigenome sequencing, and microarray analysis. The company has...
The U.S. civilian federal government awarded a $3,500 firm fixed-price purchase order for DNA sequencing services to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland and subsidiary of Macrogen, Inc. The contract, awarded on April 10, 2018, with performance to be completed by the same date, represents a ratifying order with no small business set-aside designation. Work is to be performed in Potomac, Maryland. Psomagen specializes in advanced genomic sequencing, bioinformatics, and multi-omics data analysis services, operating CLIA-certified and CAP-accredited facilities that support federal research initiatives across agencies including the National Institutes of Health, U.S. Department of Agriculture, Food and Drug Administration, and the Smithsonian Institution. This purchase order falls within Psomagen's broader portfolio of federal genomic service contracts, which have ranged from approximately $10,000 to over $500,000 in value. The company holds significant indefinite delivery vehicles with the federal government, including an $80,000 contract with USDA's Animal and Plant Health Inspection Service for Sanger sequencing and a $500 million contract with the National Heart, Lung and Blood Institute to establish and operate the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative through September 2033. These agreements position Psomagen as a key provider of sophisticated genomic research services supporting critical federal research programs in precision medicine, infectious disease, neurodegenerative disease, and agricultural genetics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/10/18 |